Therapy-persistent leukemia is selectively vulnerable to SLC23A1 restoration via targeting KHSRP [eCLIPseq]

ABSTRACT: eCLIP-seq was performed using CAL-1 cells treated with control (DMSO) or venetoclax+azacitidine (VenAza) for 6 hours to identify KHSRP-interacting RNAs

ORGANISM(S): Homo sapiens

PROVIDER: GSE301866 | GEO | 2026/07/07

REPOSITORIES: GEO